Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.17M | -4.17M | -5.31M | -5.31M | -5.51M |
| Total Depreciation and Amortization | 250.00K | 250.00K | 260.00K | 260.00K | 248.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 720.30K | 720.30K | 885.40K | 885.40K | 860.60K |
| Change in Net Operating Assets | -56.20K | -56.20K | -304.60K | -304.60K | 330.50K |
| Cash from Operations | -3.26M | -3.26M | -4.47M | -4.47M | -4.07M |
| Capital Expenditure | -600.00 | -600.00 | 7.90K | 7.90K | -60.30K |
| Sale of Property, Plant, and Equipment | -- | -- | 11.70K | 11.70K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 16.40K | 16.40K | -- |
| Other Investing Activities | -225.00K | -225.00K | 75.00K | 75.00K | -150.00K |
| Cash from Investing | -225.60K | -225.60K | 110.90K | 110.90K | -210.30K |
| Total Debt Issued | -- | -- | 670.00K | 670.00K | 1.49M |
| Total Debt Repaid | -429.70K | -429.70K | -270.60K | -270.60K | -467.00K |
| Issuance of Common Stock | 1.77M | 1.77M | 6.62M | 6.62M | 257.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.34M | 1.34M | 7.02M | 7.02M | 1.28M |
| Foreign Exchange rate Adjustments | -16.40K | -16.40K | -33.50K | -33.50K | -39.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.16M | -2.16M | 2.63M | 2.63M | -3.05M |